Basic and clinical aspects of fibrinolysis and thrombolysis.
about
Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitroEngineering of TEV protease variants by yeast ER sequestration screening (YESS) of combinatorial librariesPlasma carboxypeptidases as regulators of the plasminogen systemImpacts of tissue-type plasminogen activator (tPA) on neuronal survivalThe prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balancePlasmin-loaded echogenic liposomes for ultrasound-mediated thrombolysis.Laser enhanced high-intensity focused ultrasound thrombolysis: an in vitro study.Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cells.Tissue-type plasminogen activator is a homeostatic regulator of synaptic function in the central nervous system.Proteolytic resistance conferred to fibrinogen by von Willebrand factor.Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators.Tranexamic acid-induced ligneous conjunctivitis with renal failure showed reversible hypoplasminogenaemia.Plasminogen regulates cardiac repair after myocardial infarction through its noncanonical function in stem cell homing to the infarcted heart.A murine model of myocardial microvascular thrombosisPlasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.Targeted thrombolysis strategies for neuroprotective effectUrokinase plasminogen activator impairs SNP and PGE2 cerebrovasodilation after brain injury through activation of LRP and ERK MAPK.Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.Plasma clot lysis time and its association with cardiovascular risk factors in black Africans.tPA contributes to impairment of ATP and Ca sensitive K channel mediated cerebrovasodilation after hypoxia/ischemia through upregulation of ERK MAPK.Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.Fibrinolytic Activity of Blood and its Determinants in Healthy Medical Students.Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progressionReceptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.A Smoothened receptor agonist is neuroprotective and promotes regeneration after ischemic brain injuryUrokinase-type plasminogen activator: a new target for male contraception?Decreased fibrinolytic activity in porcine-to-primate cardiac xenotransplantationtPA contributes to impaired NMDA cerebrovasodilation after traumatic brain injury through activation of JNK MAPK.uPA modulates the age-dependent effect of brain injury on cerebral hemodynamics through LRP and ERK MAPK.Binding of the COOH-terminal lysine residue of streptokinase to plasmin(ogen) kringles enhances formation of the streptokinase.plasmin(ogen) catalytic complexes.uPA impairs cerebrovasodilation after hypoxia/ischemia through LRP and ERK MAPKEffect of Fagonia arabica on thrombin induced release of t-PA and complex of PAI-1 tPA in cultured HUVE cellsPlasminogen substrate recognition by the streptokinase-plasminogen catalytic complex is facilitated by Arg253, Lys256, and Lys257 in the streptokinase beta-domain and kringle 5 of the substrate.Cryptic peptides of the kringle domains preferentially bind to disease-associated prion protein.Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.Reduced transplant arteriosclerosis in plasminogen-deficient miceMice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways.Molecular contributions to neurovascular unit dysfunctions after brain injuries: lessons for target-specific drug development.Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves.Peptides with 6-Aminohexanoic Acid: Synthesis and Evaluation as Plasmin Inhibitors.
P2860
Q24544290-862AE57A-E9E4-41AC-9562-022D5325D80CQ24630061-82D3E1C1-13E6-4F2E-A96D-903A4403F89BQ24677226-D49804D7-088A-4748-9CE1-C1010CF49B53Q26777261-2591E357-8B09-418B-AE13-02C96FF181DEQ27003277-673CFBC6-0B91-481F-86EB-23C4D9D67F9FQ30392562-944455EB-15A6-4BA6-BB57-9690DBF75D5EQ30458285-4308926B-82B6-4CF6-8619-D84F45C910D6Q30833796-99DCD8D1-FFE8-4F27-9A09-CE5867AC8BB4Q33588521-3BBB62C7-C2E2-472A-8D20-B120FEC86E33Q33630907-BDFF0202-2790-45AC-A458-3490F084E5B6Q33680725-DFCF8B54-6188-4191-A240-811FCDD9E332Q33691725-574E4EAC-F446-4ACD-9402-3B2A25B44E7AQ33818848-0B4F42F1-7ECF-4B70-9A54-25957DF8927BQ33858132-B61773D7-D5A7-4121-B459-BB4F5C2A7850Q33909797-4290697C-BB81-40A1-9C1C-94268754760BQ34163191-38B9B8E6-E3A5-48F4-958E-1AA54AF4F5FEQ34167946-591D9BC8-F622-4B44-BD3B-C9C1402555C4Q34324817-C5FB3C75-6350-4E8C-9435-377605228AA1Q34473656-055DE3CC-7641-4D46-8059-1EE3CA357596Q34570654-7D8DD57E-5DA0-4A8C-8531-2F897607225FQ35788548-D2BF0D2D-CDAD-4C27-B92F-E4C21711B13DQ35918056-C5A7C3D1-FB6D-46C3-AA4E-8CBB8428F3F1Q35929823-DAA3211E-6C5F-4145-A197-82281F885B25Q36254926-2E10B6E0-3FE9-4B25-8535-56B50174D5E8Q36291166-BEC9335E-1D2D-4593-887D-E3AD6C935544Q36293106-F452BAA3-75C9-4DDC-B6DF-AB7C78E510EFQ36438240-93C2BE7A-5402-4B1E-9EAA-DB5E745360A9Q36469555-B6EA3514-7A55-4471-AC8E-A49C79C9A7F5Q36512703-E994D259-6E22-4352-A02E-8C33087CBBEDQ36536357-4C862A2F-0165-4A04-BC81-C269761E8972Q36948533-D1F80E40-EB61-4396-85E7-685C836ABFBCQ37074787-5C3914E3-9E6B-4FE0-A47D-8FEB28A71A94Q37339330-4FAE55AC-6C2E-481C-8E5E-8D7145AB4336Q37340572-87DDB539-5AC1-43B9-AF5A-14E5ED5C4370Q37355459-11CEFADA-91F7-4F1C-84F3-1652EBCE0B7EQ37387907-6E6AF959-915B-4484-AA72-FFBAF3BDD375Q37415725-EB3FCAEF-A24A-4E80-BE17-DABCB357D82CQ37523317-C6973B55-84FD-44D9-A147-35F76B98CC7DQ37627304-B97DC452-ED09-4BDD-9DED-13D8720E04D6Q38704015-48C0FC92-82ED-4D04-B8A3-7B4BD64010C2
P2860
Basic and clinical aspects of fibrinolysis and thrombolysis.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Basic and clinical aspects of fibrinolysis and thrombolysis.
@en
type
label
Basic and clinical aspects of fibrinolysis and thrombolysis.
@en
prefLabel
Basic and clinical aspects of fibrinolysis and thrombolysis.
@en
P1433
P1476
Basic and clinical aspects of fibrinolysis and thrombolysis
@en
P2093
P304
P407
P577
1991-12-01T00:00:00Z